Table 2. Changes of WAZ, HAZ, Hemoglobin, CD4 values and HIV RNA overtime.
| Baseline (n = 123) | 3 Months (n = 119) | 6 Months (n = 119) | 12 Months (n = 104) | P-values | |
| Nutritional status | |||||
| WAZ (mean, 95%CI*) | −1.73(−1.95,−1.50) | −1.38(−1.59,−1.17) | −1.28(−1.47,−1.08) | −1.17(−1.38,−0.96) | <0.001 |
| Underweight (WAZ<−2) (n, %) | 52(42) | 36 (30) | 31(26) | 21(20) | <0.001 |
| HAZ (mean, 95%CI*) | −2.01(−2.23,−1.80) | −1.93(−2.15,−1.71) | −1.82(−2.04,−1.60) | −1.75(−1.98,−1,51) | <0.001 |
| Stunting (HAZ<−2) (n, %) | 63(51) | 57(47) | 53(44) | 43(41) | 0.001 |
| Hemoglobin (mean, 95 CI*), g/dL | 11.6(11.3–12.0) | 12.1(11.8–12.4) | 12.2(12.0–12.4) | 12.3(12.1–12.5) | <0.001 |
| Immunological status | |||||
| Children ≥5 years, n = 74 | |||||
| CD4 T-cells (median, IQR) | 337(236–484) | 500(345–675) | 567(365–765) | 620(375–880) | <0.001 |
| CD4 T-cells <500, n (%), | 57(79) | 34(49) | 29(40) | 22(34) | <0.001 |
| Children <5 years, n = 49 | |||||
| CD4 T-cell % (median, IQR) | 20(13–28) | 29(22–36) | 33(26–39) | 36(28–41) | <0.001 |
| CD4T-cell <25%, n (%), | 30(65) | 17(38) | 11(24) | 5(13) | <0.001 |
| Virological status (HIV-RNA) | |||||
| <40 (copies/mL), n (%) | 0(0) | Not determined | 52(43) | 79(76) | <0.001 |
| >1000 copies/mL, n (%) | 123(100) | 46(38) | 17(16) | <0.001 | |
P values bold: Changes over time for all variables were statistically significant at p<0.05 using a univariate Generalized estimating equation model for categorical, normal and no normal distributed outcomes.